Publisher
Springer International Publishing
Reference42 articles.
1. Aguirre Ghiso JA, Alonso DF, Farías EF, Gomez DE, de Kier Joffè EB. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem. 1999;263:295–304.
2. Alfano M, Sidenius N, Panzeri B, et al. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc Natl Acad Sci U S A. 2002;99:8862–7.
3. Behrendt N, Ronne E, Ploug M, Petri T, Lober D, Nielsen LS, Schleuning W-D, Blasi F, Appella E, Dano K. The human receptor for urokinase plasminogen activator. J Biol Chem. 1990;265:6453–60.
4. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K. The ligand-binding domain of the cell surface receptor for urokinasetype plasminogen activator. J Biol Chem. 1991;266:7842–7.
5. Béné MC, Castoldi G, Knapp W, et al. EGIL, European Group on Immunological Classification of Leukemias. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review. Leukemia. 2004;18:394–400.